KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in IntangiblesChange in IntangiblesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Depreciation & Amortization (CF) (2018 - 2026)

Astrazeneca has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $1.4 billion for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (CF) rose 6.39% year-over-year to $1.4 billion; the TTM value through Mar 2026 reached $5.8 billion, down 13.43%, while the annual FY2025 figure was $5.7 billion, 14.28% down from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 was $1.4 billion at Astrazeneca, down from $1.5 billion in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $4.0 billion in Q4 2022 and troughed at $1.3 billion in Q1 2024.
  • A 5-year average of $1.7 billion and a median of $1.4 billion in 2025 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 107.87% in 2022 and later plummeted 35.34% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $4.0 billion in 2022, then crashed by 68.1% to $1.3 billion in 2023, then surged by 83.15% to $2.3 billion in 2024, then plummeted by 35.34% to $1.5 billion in 2025, then fell by 9.6% to $1.4 billion in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for AZN at $1.4 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.5 billion in Q3 2025.